Clinical Trial Update: Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of PBF-509 in healthy male volunteers; Parkinson's disease is listed as the associated condition for the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• PBF-509

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED